Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neuphoria Therapeutics (NEUP) Other Non Operating Income (2024 - 2025)

Historic Other Non Operating Income for Neuphoria Therapeutics (NEUP) over the last 2 years, with Q4 2025 value amounting to $5.4 million.

  • Neuphoria Therapeutics' Other Non Operating Income rose 56791.07% to $5.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$3.1 million, marking a year-over-year change of. This contributed to the annual value of -$414996.0 for FY2025, which is 11880.0% down from last year.
  • As of Q4 2025, Neuphoria Therapeutics' Other Non Operating Income stood at $5.4 million, which was up 56791.07% from -$4.4 million recorded in Q3 2025.
  • Neuphoria Therapeutics' 5-year Other Non Operating Income high stood at $5.4 million for Q4 2025, and its period low was -$4.4 million during Q3 2025.